메뉴 건너뛰기




Volumn 48, Issue 9, 2013, Pages 995-1009

Microbiota in health and irritable bowel syndrome: Current knowledge, perspectives and therapeutic options

Author keywords

Antibiotic; Gastrointestinal tract; Irritable bowel syndrome; Microbiota; Prebiotic; Probiotic; Synbiotic

Indexed keywords

ANTIBIOTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FLAGELLIN; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; METRONIDAZOLE; NEOMYCIN; NEUROTROPHIN; PLACEBO; PREBIOTIC AGENT; PROBIOTIC AGENT; RAFTILOSE; RIFAXIMIN; RNA 16S; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT; UNCLASSIFIED DRUG; VITAMIN B COMPLEX; VITAMIN K GROUP;

EID: 84883012986     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2013.799220     Document Type: Review
Times cited : (53)

References (146)
  • 2
    • 80955180995 scopus 로고    scopus 로고
    • Intestinal microbiota in human health and disease: The impact of probiotics
    • Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: The impact of probiotics. Genes Nutr 2011;6:209-40
    • (2011) Genes Nutr , vol.6 , pp. 209-240
    • Gerritsen, J.1    Smidt, H.2    Rijkers, G.T.3    De Vos, W.M.4
  • 4
    • 84857039557 scopus 로고    scopus 로고
    • The intestinal microbiota in health and disease
    • Young VB. The intestinal microbiota in health and disease. Curr Opin Gastroenterol 2011;28:63-9
    • (2011) Curr Opin Gastroenterol , vol.28 , pp. 63-69
    • Young, V.B.1
  • 6
    • 84880142246 scopus 로고    scopus 로고
    • Contribution of the intestinal microbiota to human health: From birth to 100 years of age
    • Cheng J, Palva AM, de Vos WM, Satokari R. Contribution of the intestinal microbiota to human health: From birth to 100 years of age. Curr Top Microbiol Immunol 2013;358: 323-46
    • (2013) Curr Top Microbiol Immunol , vol.358 , pp. 323-346
    • Cheng, J.1    Palva, A.M.2    De Vos, W.M.3    Satokari, R.4
  • 7
    • 82355188259 scopus 로고    scopus 로고
    • Gut microbiota and probiotics in maternal and infant health
    • Sanz Y. Gut microbiota and probiotics in maternal and infant health. Am J Clin Nutr 2011;94:2000S-5S.
    • (2011) Am J Clin Nutr , vol.94
    • Sanz, Y.1
  • 8
    • 0031126531 scopus 로고    scopus 로고
    • The intestinal microflora during the first weeks of life
    • DOI 10.1006/anae.1997.0102
    • Bezirtzoglou E. The intestinal microflora during the first weeks of life. Anaerobe 1997;3:173-7 (Pubitemid 27423147)
    • (1997) Anaerobe , vol.3 , Issue.2-3 , pp. 173-177
    • Bezirtzoglou, E.1
  • 9
    • 78049502664 scopus 로고    scopus 로고
    • Longitudinal investigation of the faecal microbiota of healthy full-Term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis
    • Roger LC, McCartney AL. Longitudinal investigation of the faecal microbiota of healthy full-Term infants using fluorescence in situ hybridization and denaturing gradient gel electrophoresis. Microbiology 2010;156:3317-28
    • (2010) Microbiology , vol.156 , pp. 3317-3328
    • Roger, L.C.1    McCartney, A.L.2
  • 10
    • 78049504118 scopus 로고    scopus 로고
    • Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life
    • Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology 2010;156:3329-41
    • (2010) Microbiology , vol.156 , pp. 3329-3341
    • Roger, L.C.1    Costabile, A.2    Holland, D.T.3    Hoyles, L.4    McCartney, A.L.5
  • 11
    • 58449119188 scopus 로고    scopus 로고
    • Establishment of the gut microbiota in Western infants
    • Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009;98:229-38
    • (2009) Acta Paediatr , vol.98 , pp. 229-238
    • Adlerberth, I.1    Wold, A.E.2
  • 14
    • 0026451450 scopus 로고
    • In vivo and in vitro models of the human colonic flora
    • Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 1992;31:299-331
    • (1992) Crit Rev Food Sci Nutr , vol.31 , pp. 299-331
    • Rumney, C.J.1    Rowland, I.R.2
  • 17
    • 34547683600 scopus 로고    scopus 로고
    • Diversity of the human gastrointestinal tract microbiota revisited
    • DOI 10.1111/j.1462-2920.2007.01369.x
    • Rajilic-Stojanovic M, Smidt H, de Vos WM. Diversity of the human gastrointestinal tract microbiota revisited. Environ Microbiol 2007;9:2125-36 (Pubitemid 47222128)
    • (2007) Environmental Microbiology , vol.9 , Issue.9 , pp. 2125-2136
    • Rajilic-Stojanovic, M.1    Smidt, H.2    De Vos, W.M.3
  • 19
    • 42349093774 scopus 로고    scopus 로고
    • Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques
    • DOI 10.1038/nrmicro1888, PII NRMICRO1888
    • Amann R, Fuchs BM. Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat Rev Microbiol 2008;6:339-48 (Pubitemid 351552655)
    • (2008) Nature Reviews Microbiology , vol.6 , Issue.5 , pp. 339-348
    • Amann, R.1    Fuchs, B.M.2
  • 20
    • 9644268216 scopus 로고    scopus 로고
    • Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR
    • DOI 10.1111/j.1365-2672.2004.02409.x
    • Rinttila T, Kassinen A, Malinen E, Krogius L, Palva A. Development of an extensive set of 16S rDNA-Targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-Time PCR. J Appl Microbiol 2004;97:1166-77 (Pubitemid 39573940)
    • (2004) Journal of Applied Microbiology , vol.97 , Issue.6 , pp. 1166-1177
    • Rinttila, T.1    Kassinen, A.2    Malinen, E.3    Krogius, L.4    Palva, A.5
  • 21
    • 23744446233 scopus 로고    scopus 로고
    • Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis
    • DOI 10.1128/AEM.71.8.4679-4689.2005
    • Ben-Amor K, Heilig H, Smidt H, Vaughan EE, Abee T, de Vos WM. Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-Activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 2005; 71:4679-89 (Pubitemid 41129525)
    • (2005) Applied and Environmental Microbiology , vol.71 , Issue.8 , pp. 4679-4689
    • Ben-Amor, K.1    Heilig, H.2    Smidt, H.3    Vaughan, E.E.4    Abee, T.5    De Vos, W.M.6
  • 23
    • 79953204638 scopus 로고    scopus 로고
    • Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples
    • van den Bogert B, de Vos WM, Zoetendal EG, Kleerebezem M. Microarray analysis and barcoded pyrosequencing provide consistent microbial profiles depending on the source of human intestinal samples. Appl Environ Microbiol 2011;77:2071-80
    • (2011) Appl Environ Microbiol , vol.77 , pp. 2071-2080
    • Van Den Bogert, B.1    De Vos, W.M.2    Zoetendal, E.G.3    Kleerebezem, M.4
  • 24
    • 54349126970 scopus 로고    scopus 로고
    • High-Throughput diversity and functionality analysis of the gastrointestinal tract microbiota
    • Zoetendal EG, Rajilic-Stojanovic M, De Vos WM. High-Throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008;57:1605-15
    • (2008) Gut , vol.57 , pp. 1605-1615
    • Zoetendal, E.G.1    Rajilic-Stojanovic, M.2    De Vos, W.M.3
  • 27
    • 77950251400 scopus 로고    scopus 로고
    • A human gut microbial gene catalogue established by metagenomic sequencing
    • Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464: 59-65
    • (2010) Nature , vol.464 , pp. 59-65
    • Qin, J.1    Li, R.2    Raes, J.3    Arumugam, M.4    Burgdorf, K.S.5    Manichanh, C.6
  • 29
    • 33845901507 scopus 로고    scopus 로고
    • Microbial ecology: Human gut microbes associated with obesity
    • DOI 10.1038/4441022a, PII 4441022A
    • Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: Human gut microbes associated with obesity. Nature 2006;444:1022-3 (Pubitemid 46018512)
    • (2006) Nature , vol.444 , Issue.7122 , pp. 1022-1023
    • Ley, R.E.1    Turnbaugh, P.J.2    Klein, S.3    Gordon, J.I.4
  • 31
    • 34547507259 scopus 로고    scopus 로고
    • Microbial communities in the human small intestine: Coupling diversity to metagenomics
    • DOI 10.2217/17460913.2.3.285
    • Booijink CC, Zoetendal EG, Kleerebezem M, de Vos WM. Microbial communities in the human small intestine: Coupling diversity to metagenomics. Future Microbiol 2007;2: 285-95 (Pubitemid 47180925)
    • (2007) Future Microbiology , vol.2 , Issue.3 , pp. 285-295
    • Booijink, C.C.G.M.1    Zoetendal, E.G.2    Kleerebezem, M.3    De Vos, W.M.4
  • 32
    • 80054957238 scopus 로고    scopus 로고
    • Microflora modulation of motility
    • Quigley EM. Microflora modulation of motility. J Neurogastroenterol Motil 2011;17:140-7
    • (2011) J Neurogastroenterol Motil , vol.17 , pp. 140-147
    • Quigley, E.M.1
  • 33
    • 0037425743 scopus 로고    scopus 로고
    • Gut flora in health and disease
    • DOI 10.1016/S0140-6736(03)12489-0
    • Guarner F, Malagelada Jr. Gut flora in health and disease. Lancet 2003;361:512-19 (Pubitemid 36173720)
    • (2003) Lancet , vol.361 , Issue.9356 , pp. 512-519
    • Guarner, F.1    Malagelada, J.-R.2
  • 34
    • 56849106496 scopus 로고    scopus 로고
    • The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing
    • Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280
    • (2008) PLoS Biol , vol.6
    • Dethlefsen, L.1    Huse, S.2    Sogin, M.L.3    Relman, D.A.4
  • 36
    • 69849114201 scopus 로고    scopus 로고
    • The degree of microbiome complexity influences the epithelial response to infection
    • Mans JJ, von LK, Dorsey C, Willis S, Wallet SM, Baker HV, et al. The degree of microbiome complexity influences the epithelial response to infection. BMC Genomics 2009;10:380
    • (2009) BMC Genomics , vol.10 , pp. 380
    • Mans, J.J.1    Von, L.K.2    Dorsey, C.3    Willis, S.4    Wallet, S.M.5    Baker, H.V.6
  • 37
    • 20444493331 scopus 로고    scopus 로고
    • The interaction between bacteria and bile
    • DOI 10.1016/j.femsre.2004.09.003, PII S0168644504000646
    • Begley M, Gahan CG, Hill C. The interaction between bacteria and bile. FEMS Microbiol Rev 2005;29:625-51 (Pubitemid 41139175)
    • (2005) FEMS Microbiology Reviews , vol.29 , Issue.4 , pp. 625-651
    • Begley, M.1    Gahan, C.G.M.2    Hill, C.3
  • 38
    • 33244467651 scopus 로고    scopus 로고
    • Bile salt biotransformations by human intestinal bacteria
    • DOI 10.1194/jlr.R500013-JLR200
    • Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006;47:241-59 (Pubitemid 43276911)
    • (2006) Journal of Lipid Research , vol.47 , Issue.2 , pp. 241-259
    • Ridlon, J.M.1    Kang, D.-J.2    Hylemon, P.B.3
  • 39
    • 58249110568 scopus 로고    scopus 로고
    • Role of bile acids and bile acid receptors in metabolic regulation
    • Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147-91
    • (2009) Physiol Rev , vol.89 , pp. 147-191
    • Lefebvre, P.1    Cariou, B.2    Lien, F.3    Kuipers, F.4    Staels, B.5
  • 41
    • 41449101412 scopus 로고    scopus 로고
    • Short chain fatty acids and colonic health
    • Hijova E, Chmelarova A. Short chain fatty acids and colonic health. Bratisl Lek Listy 2007;108:354-8
    • (2007) Bratisl Lek Listy , vol.108 , pp. 354-358
    • Hijova, E.1    Chmelarova, A.2
  • 43
    • 84862017188 scopus 로고    scopus 로고
    • Gut microbiota and nonalcoholic fatty liver disease
    • Machado MV, Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 2012;11:440-9
    • (2012) Ann Hepatol , vol.11 , pp. 440-449
    • Machado, M.V.1    Cortez-Pinto, H.2
  • 44
    • 79957902145 scopus 로고    scopus 로고
    • Gut microbiome, obesity, and metabolic dysfunction
    • Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011;121:2126-32
    • (2011) J Clin Invest , vol.121 , pp. 2126-2132
    • Tilg, H.1    Kaser, A.2
  • 45
    • 78650465542 scopus 로고    scopus 로고
    • Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk
    • Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010;31:817-44
    • (2010) Endocr Rev , vol.31 , pp. 817-844
    • Manco, M.1    Putignani, L.2    Bottazzo, G.F.3
  • 46
    • 84857729398 scopus 로고    scopus 로고
    • Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota
    • Serino M, Luche E, Gres S, Baylac A, Berge M, Cenac C, et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012;61: 543-53
    • (2012) Gut , vol.61 , pp. 543-553
    • Serino, M.1    Luche, E.2    Gres, S.3    Baylac, A.4    Berge, M.5    Cenac, C.6
  • 47
    • 84858590812 scopus 로고    scopus 로고
    • Gut microbiota: Next frontier in understanding human health and development of biotherapeutics
    • Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C. Gut microbiota: Next frontier in understanding human health and development of biotherapeutics. Biologics 2011;5:71-86
    • (2011) Biologics , vol.5 , pp. 71-86
    • Prakash, S.1    Rodes, L.2    Coussa-Charley, M.3    Tomaro-Duchesneau, C.4
  • 48
    • 77954051526 scopus 로고    scopus 로고
    • Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses
    • Hapfelmeier S, Lawson MA, Slack E, Kirundi JK, Stoel M, Heikenwalder M, et al. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 2010;328:1705-9
    • (2010) Science , vol.328 , pp. 1705-1709
    • Hapfelmeier, S.1    Lawson, M.A.2    Slack, E.3    Kirundi, J.K.4    Stoel, M.5    Heikenwalder, M.6
  • 49
    • 85027947787 scopus 로고    scopus 로고
    • Induction of colonic regulatory T cells by indigenous clostridium species
    • Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous clostridium species. Science 2011;331:337-41
    • (2011) Science , vol.331 , pp. 337-341
    • Atarashi, K.1    Tanoue, T.2    Shima, T.3    Imaoka, A.4    Kuwahara, T.5    Momose, Y.6
  • 50
    • 70350343544 scopus 로고    scopus 로고
    • Induction of intestinal Th17 cells by segmented filamentous bacteria
    • Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009;139:485-98
    • (2009) Cell , vol.139 , pp. 485-498
    • Ivanov, I.I.1    Atarashi, K.2    Manel, N.3    Brodie, E.L.4    Shima, T.5    Karaoz, U.6
  • 52
    • 70350666634 scopus 로고    scopus 로고
    • Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43
    • Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009;461:1282-6
    • (2009) Nature , vol.461 , pp. 1282-1286
    • Maslowski, K.M.1    Vieira, A.T.2    Ng, A.3    Kranich, J.4    Sierro, F.5    Yu, D.6
  • 53
    • 23044509165 scopus 로고    scopus 로고
    • Modulation of gut mucosal biofilms
    • DOI 10.1079/BJN20041346
    • Kleessen B, Blaut M. Modulation of gut mucosal biofilms. Br J Nutr 2005;93:S35-40 (Pubitemid 43073405)
    • (2005) British Journal of Nutrition , vol.93 , Issue.SUPPL.
    • Kleessen, B.1    Blaut, M.2
  • 55
    • 0031812434 scopus 로고    scopus 로고
    • Presidential address: Gastrointestinal illness and the biopsychosocial model
    • Drossman DA. Presidential address: Gastrointestinal illness and the biopsychosocial model. Psychosom Med 1998;60: 258-67 (Pubitemid 28279969)
    • (1998) Psychosomatic Medicine , vol.60 , Issue.3 , pp. 258-267
    • Drossman, D.A.1
  • 56
    • 84872296174 scopus 로고    scopus 로고
    • Voices from within: Gut microbes and the CNS
    • Forsythe P, Kunze WA. Voices from within: Gut microbes and the CNS. Cell Mol Life Sci 2013;70:55-69
    • (2013) Cell Mol Life Sci , vol.70 , pp. 55-69
    • Forsythe, P.1    Kunze, W.A.2
  • 57
    • 67650333217 scopus 로고    scopus 로고
    • Principles and clinical implications of the brain-gut-enteric microbiota axis
    • Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009;6:306-14
    • (2009) Nat Rev Gastroenterol Hepatol , vol.6 , pp. 306-314
    • Rhee, S.H.1    Pothoulakis, C.2    Mayer, E.A.3
  • 58
    • 79551694651 scopus 로고    scopus 로고
    • The microbiome-gut-brain axis: From bowel to behavior
    • Cryan JF, O'Mahony SM. The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil 2011;23: 187-92
    • (2011) Neurogastroenterol Motil , vol.23 , pp. 187-192
    • Cryan, J.F.1    O'Mahony, S.M.2
  • 59
    • 4043161248 scopus 로고    scopus 로고
    • Postnatal microbial colonization programs the hypothalamic-pituitary- adrenal system for stress response in mice
    • DOI 10.1113/jphysiol.2004.063388
    • Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-Adrenal system for stress response in mice. J Physiol 2004;558:263-75 (Pubitemid 39077406)
    • (2004) Journal of Physiology , vol.558 , Issue.1 , pp. 263-275
    • Sudo, N.1    Chida, Y.2    Aiba, Y.3    Sonoda, J.4    Oyama, N.5    Yu, X.-N.6    Kubo, C.7    Koga, Y.8
  • 60
    • 79551713705 scopus 로고    scopus 로고
    • Reduced anxiety-like behavior and central neurochemical change in germ-free mice
    • e119
    • Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011;23:255-64, e119
    • (2011) Neurogastroenterol Motil , vol.23 , pp. 255-264
    • Neufeld, K.M.1    Kang, N.2    Bienenstock, J.3    Foster, J.A.4
  • 63
    • 81855194317 scopus 로고    scopus 로고
    • The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication
    • Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011;23:1132-9
    • (2011) Neurogastroenterol Motil , vol.23 , pp. 1132-1139
    • Bercik, P.1    Park, A.J.2    Sinclair, D.3    Khoshdel, A.4    Lu, J.5    Huang, X.6
  • 64
    • 78149501207 scopus 로고    scopus 로고
    • Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice
    • Bercik P, Verdu EF, Foster JA, Macri J, Potter M, Huang X, et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010;139:2102-12
    • (2010) Gastroenterology , vol.139 , pp. 2102-2112
    • Bercik, P.1    Verdu, E.F.2    Foster, J.A.3    Macri, J.4    Potter, M.5    Huang, X.6
  • 65
    • 80052965474 scopus 로고    scopus 로고
    • Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve
    • Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108:16050-5
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 16050-16055
    • Bravo, J.A.1    Forsythe, P.2    Chew, M.V.3    Escaravage, E.4    Savignac, H.M.5    Dinan, T.G.6
  • 68
    • 20444374493 scopus 로고    scopus 로고
    • Activation in vagal afferents and central autonomic pathways: Early responses to intestinal infection with Campylobacter jejuni
    • DOI 10.1016/j.bbi.2004.09.002, PII S0889159104001278
    • Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N, Lyte M. Activation in vagal afferents and central autonomic pathways: Early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 2005;19:334-44 (Pubitemid 40797990)
    • (2005) Brain, Behavior, and Immunity , vol.19 , Issue.4 , pp. 334-344
    • Goehler, L.E.1    Gaykema, R.P.A.2    Opitz, N.3    Reddaway, R.4    Badr, N.5    Lyte, M.6
  • 70
    • 0036893761 scopus 로고    scopus 로고
    • AGA technical review on irritable bowel syndrome
    • DOI 10.1053/gast.2002.37095
    • Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002;123:2108-31 (Pubitemid 35408332)
    • (2002) Gastroenterology , vol.123 , Issue.6 , pp. 2108-2131
    • Drossman, D.A.1    Camilleri, M.2    Mayer, E.A.3    Whitehead, W.E.4
  • 71
    • 0034530999 scopus 로고    scopus 로고
    • Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBD)
    • DOI 10.1023/A:1010770302403
    • Simren M, Castedal M, Svedlund J, Abrahamsson H, Bjornsson E. Abnormal propagation pattern of duodenal pressure waves in the irritable bowel syndrome (IBS) [correction of (IBD)]. Dig Dis Sci 2000;45:2151-61 (Pubitemid 32060385)
    • (2000) Digestive Diseases and Sciences , vol.45 , Issue.11 , pp. 2151-2161
    • Simren, M.1    Castedal, M.2    Svedlund, J.3    Abrahamsson, H.4    Bjornsson, E.5
  • 72
    • 0022352734 scopus 로고
    • The irritable bowel syndrome: A proxysmal disorder
    • Kumar D, Wingate DL. The irritable bowel syndrome: A paroxysmal motor disorder. Lancet 1985;2:973-7 (Pubitemid 16215443)
    • (1985) Lancet , vol.2 , Issue.8462 , pp. 973-977
    • Kumar, D.1    Wingate, D.L.2
  • 75
    • 0036079899 scopus 로고    scopus 로고
    • Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds
    • Bouin M, Plourde V, Boivin M, Riberdy M, Lupien F, Laganiere M, et al. Rectal distention testing in patients with irritable bowel syndrome: Sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002;122:1771-7 (Pubitemid 34651420)
    • (2002) Gastroenterology , vol.122 , Issue.7 , pp. 1771-1777
    • Bouin, M.1    Plourde, V.2    Boivin, M.3    Riberdy, M.4    Lupien, F.5    Laganiere, M.6    Verrier, P.7    Poitras, P.8
  • 77
    • 33749039592 scopus 로고    scopus 로고
    • Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome
    • Nozu T, KudairaM, Kitamori S, Uehara A. Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome. J Gastroenterol 2006;41:217-22
    • (2006) J Gastroenterol , vol.41 , pp. 217-222
    • Nozu, T.1    KudairaM Kitamori, S.2    Uehara, A.3
  • 80
  • 81
    • 34547477105 scopus 로고    scopus 로고
    • Systematic review and meta-analysis: The incidence and prognosis of post-infectious irritable bowel syndrome
    • DOI 10.1111/j.1365-2036.2007.03399.x
    • Thabane M, Kottachchi DT, Marshall JK. Systematic review and meta-Analysis: The incidence and prognosis of post-infectious irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:535-44 (Pubitemid 47174284)
    • (2007) Alimentary Pharmacology and Therapeutics , vol.26 , Issue.4 , pp. 535-544
    • Thabane, M.1    Kottachchi, D.T.2    Marshall, J.K.3
  • 83
    • 79952305589 scopus 로고    scopus 로고
    • The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome
    • Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology 2011;140:761-5
    • (2011) Gastroenterology , vol.140 , pp. 761-765
    • Chang, L.1
  • 85
    • 12844273701 scopus 로고    scopus 로고
    • Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome - A longitudinal study in IBS and control subjects
    • DOI 10.1016/j.femsim.2004.08.009, PII S0928824404001889
    • Matto J, Maunuksela L, Kajander K, Palva A, Korpela R, Kassinen A, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome-A longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol 2005;43:213-22 (Pubitemid 40170291)
    • (2005) FEMS Immunology and Medical Microbiology , vol.43 , Issue.2 , pp. 213-222
    • Matto, J.1    Maunuksela, L.2    Kajander, K.3    Palva, A.4    Riitta Korpela5    Anna Kassinen6    Saarela, M.7
  • 86
    • 33646259477 scopus 로고    scopus 로고
    • Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria
    • Maukonen J, Satokari R, Matto J, Soderlund H, Mattila-Sandholm T, Saarela M. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 2006;55:625-33
    • (2006) J Med Microbiol , vol.55 , pp. 625-633
    • Maukonen, J.1    Satokari, R.2    Matto, J.3    Soderlund, H.4    Mattila-Sandholm, T.5    Saarela, M.6
  • 87
    • 76849116160 scopus 로고    scopus 로고
    • A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome
    • Codling C, O'Mahony L, Shanahan F, Quigley EM, Marchesi Jr. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci 2010;55:392-7
    • (2010) Dig Dis Sci , vol.55 , pp. 392-397
    • Codling, C.1    O'Mahony, L.2    Shanahan, F.3    Quigley, E.M.4    Marchesi, J.R.5
  • 89
    • 74549200558 scopus 로고    scopus 로고
    • Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification
    • Lyra A, Rinttila T, Nikkila J, Krogius-Kurikka L, Kajander K, Malinen E, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol 2009;15: 5936-45
    • (2009) World J Gastroenterol , vol.15 , pp. 5936-5945
    • Lyra, A.1    Rinttila, T.2    Nikkila, J.3    Krogius-Kurikka, L.4    Kajander, K.5    Malinen, E.6
  • 90
    • 77950670562 scopus 로고    scopus 로고
    • Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome
    • Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010;22:512-15
    • (2010) Neurogastroenterol Motil , vol.22 , pp. 512-515
    • Tana, C.1    Umesaki, Y.2    Imaoka, A.3    Handa, T.4    Kanazawa, M.5    Fukudo, S.6
  • 91
    • 79957601426 scopus 로고    scopus 로고
    • Microbial community and metabolomic comparison of irritable bowel syndrome faeces
    • Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 2011;60:817-27
    • (2011) J Med Microbiol , vol.60 , pp. 817-827
    • Ponnusamy, K.1    Choi, J.N.2    Kim, J.3    Lee, S.Y.4    Lee, C.H.5
  • 92
    • 0032505571 scopus 로고    scopus 로고
    • Abnormal colonic fermentation in irritable bowel syndrome
    • DOI 10.1016/S0140-6736(98)02146-1
    • King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352:1187-9 (Pubitemid 28458534)
    • (1998) Lancet , vol.352 , Issue.9135 , pp. 1187-1189
    • King, T.S.1    Elia, M.2    Hunter, J.O.3
  • 94
    • 74549185684 scopus 로고    scopus 로고
    • Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers
    • Krogius-Kurikka L, Lyra A, Malinen E, Aarnikunnas J, Tuimala J, Paulin L, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol 2009;9: 95
    • (2009) BMC Gastroenterol , vol.9 , pp. 95
    • Krogius-Kurikka, L.1    Lyra, A.2    Malinen, E.3    Aarnikunnas, J.4    Tuimala, J.5    Paulin, L.6
  • 95
    • 0035059367 scopus 로고    scopus 로고
    • Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain
    • DOI 10.1016/S0304-3959(00)00467-X, PII S030439590000467X
    • Michl T, Jocic M, Heinemann A, Schuligoi R, Holzer P. Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 2001;92:19-27 (Pubitemid 32367933)
    • (2001) Pain , vol.92 , Issue.1-2 , pp. 19-27
    • Michl, T.1    Jocic, M.2    Heinemann, A.3    Schuligoi, R.4    Holzer, P.5
  • 96
    • 22144476548 scopus 로고    scopus 로고
    • Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease
    • DOI 10.1128/JCM.43.7.3380-3389.2005
    • Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 2005;43:3380-9 (Pubitemid 40981351)
    • (2005) Journal of Clinical Microbiology , vol.43 , Issue.7 , pp. 3380-3389
    • Swidsinski, A.1    Weber, J.2    Loening-Baucke, V.3    Hale, L.P.4    Lochs, H.5
  • 97
    • 80051785670 scopus 로고    scopus 로고
    • Luminal and mucosal-Associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
    • Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-Associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathogens 2010;2:19
    • (2010) Gut Pathogens , vol.2 , pp. 19
    • Carroll, I.M.1    Chang, Y.H.2    Park, J.3    Sartor, R.B.4    Ringel, Y.5
  • 98
    • 67651252736 scopus 로고    scopus 로고
    • Lower Bifidobacteria counts in both duodenal mucosa-Associated and fecal microbiota in irritable bowel syndrome patients
    • Kerckhoffs AP, Samsom M, van der Rest ME, de VJ, Knol J, Ben-Amor K, et al. Lower Bifidobacteria counts in both duodenal mucosa-Associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 2009;15: 2887-92
    • (2009) World J Gastroenterol , vol.15 , pp. 2887-2892
    • Kerckhoffs, A.P.1    Samsom, M.2    Van Der Rest, M.E.3    De, V.J.4    Knol, J.5    Ben-Amor, K.6
  • 99
    • 84870866715 scopus 로고    scopus 로고
    • An Update on post-infectious irritable bowel syndrome: Role of genetics, immune activation, serotonin and altered microbiome
    • Spiller R, Lam C. An Update on post-infectious irritable bowel syndrome: Role of genetics, immune activation, serotonin and altered microbiome. J Neurogastroenterol Motil 2012;18:258-68
    • (2012) J Neurogastroenterol Motil , vol.18 , pp. 258-268
    • Spiller, R.1    Lam, C.2
  • 101
    • 78049496695 scopus 로고    scopus 로고
    • Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives
    • Salonen A, de Vos WM, Palva A. Gastrointestinal microbiota in irritable bowel syndrome: Present state and perspectives. Microbiology 2010;156:3205-15
    • (2010) Microbiology , vol.156 , pp. 3205-3215
    • Salonen, A.1    De Vos, W.M.2    Palva, A.3
  • 102
    • 3242728473 scopus 로고    scopus 로고
    • FAO/WHO Basel, Switzerland: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria
    • FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Basel, Switzerland: Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria; 2001
    • (2001) Health And Nutritional Properties Of Probiotics In Food Including Powder Milk With Live Lactic Acid Bacteria
  • 103
    • 40749160476 scopus 로고    scopus 로고
    • Probiotics in irritable bowel syndrome an immunomodulatory strategy?
    • Quigley EM. Probiotics in irritable bowel syndrome: An immunomodulatory strategy? J Am Coll Nutr 2007; 26:684S-90S.
    • (2007) J Am Coll Nutr , vol.26
    • Quigley, E.M.1
  • 104
    • 65449125343 scopus 로고    scopus 로고
    • Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gastroenterology enters the metagenomics era
    • Preidis GA, Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: Gastroenterology enters the metagenomics era. Gastroenterology 2009;136: 2015-31
    • (2009) Gastroenterology , vol.136 , pp. 2015-2031
    • Preidis, G.A.1    Versalovic, J.2
  • 105
    • 33846926968 scopus 로고    scopus 로고
    • Probiotics and irritable bowel syndrome: A rationale for their use and an assessment of the evidence to date
    • DOI 10.1111/j.1365-2982.2006.00879.x
    • Quigley EM, Flourie B. Probiotics and irritable bowel syndrome: A rationale for their use and an assessment of the evidence to date. Neurogastroenterol Motil 2007;19: 166-72 (Pubitemid 46239427)
    • (2007) Neurogastroenterology and Motility , vol.19 , Issue.3 , pp. 166-172
    • Quigley, E.M.M.1    Flourie, B.2
  • 106
    • 77954832198 scopus 로고    scopus 로고
    • Probiotics-host communication: Modulation of signaling pathways in the intestine
    • Thomas CM, Versalovic J. Probiotics-host communication: Modulation of signaling pathways in the intestine. Gut Microbes 2010;1:148-63
    • (2010) Gut Microbes , vol.1 , pp. 148-163
    • Thomas, C.M.1    Versalovic, J.2
  • 107
    • 0033921870 scopus 로고    scopus 로고
    • Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study
    • O'Sullivan MA, O'Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000;32: 294-301 (Pubitemid 30445067)
    • (2000) Digestive and Liver Disease , vol.32 , Issue.4 , pp. 294-301
    • O'Sullivan, M.A.1    O'Morain, C.A.2
  • 108
    • 0034059773 scopus 로고    scopus 로고
    • Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome
    • DOI 10.1016/S0002-9270(00)00807-8, PII S0002927000008078
    • Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231-8 (Pubitemid 30263518)
    • (2000) American Journal of Gastroenterology , vol.95 , Issue.5 , pp. 1231-1238
    • Nobaek, S.1    Johansson, M.-L.2    Molin, G.3    Ahrne, S.4    Jeppsson, B.5
  • 110
    • 65449172901 scopus 로고    scopus 로고
    • The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review
    • Brenner DM, Moeller MJ, Chey WD, Schoenfeld PS. The utility of probiotics in the treatment of irritable bowel syndrome: A systematic review. Am J Gastroenterol 2009; 104:1033-49
    • (2009) Am J Gastroenterol , vol.104 , pp. 1033-1049
    • Brenner, D.M.1    Moeller, M.J.2    Chey, W.D.3    Schoenfeld, P.S.4
  • 113
    • 77749318556 scopus 로고    scopus 로고
    • The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review
    • Moayyedi P, Ford AC, Talley NJ, Cremonini F, Foxx-Orenstein AE, Brandt LJ, et al. The efficacy of probiotics in the treatment of irritable bowel syndrome: A systematic review. Gut 2010;59:325-32
    • (2010) Gut , vol.59 , pp. 325-332
    • Moayyedi, P.1    Ford, A.C.2    Talley, N.J.3    Cremonini, F.4    Foxx-Orenstein, A.E.5    Brandt, L.J.6
  • 114
    • 58149105515 scopus 로고    scopus 로고
    • Probiotics and irritable bowel syndrome: Rationale, mechanisms, and efficacy
    • Camilleri M. Probiotics and irritable bowel syndrome: Rationale, mechanisms, and efficacy. J Clin Gastroenterol 2008;42:S123-5
    • (2008) J Clin Gastroenterol , vol.42
    • Camilleri, M.1
  • 115
    • 49649088887 scopus 로고    scopus 로고
    • Meta-Analysis of probiotics for the treatment of irritable bowel syndrome
    • McFarland LV, Dublin S. Meta-Analysis of probiotics for the treatment of irritable bowel syndrome. World J Gastroenterol 2008;14:2650-61
    • (2008) World J Gastroenterol , vol.14 , pp. 2650-2661
    • McFarland, L.V.1    Dublin, S.2
  • 116
    • 68649111410 scopus 로고    scopus 로고
    • Alterations in the intestinal microbiota and functional bowel symptoms
    • vii
    • Ringel Y, Carroll IM. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am 2009;19:141-50, vii
    • (2009) Gastrointest Endosc Clin N Am , vol.19 , pp. 141-150
    • Ringel, Y.1    Carroll, I.M.2
  • 117
    • 4844226594 scopus 로고    scopus 로고
    • Probiotics in the treatment of irritable bowel syndrome
    • Saggioro A. Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol 2004;38:S104-6
    • (2004) J Clin Gastroenterol , vol.38
    • Saggioro, A.1
  • 119
    • 43149106687 scopus 로고    scopus 로고
    • A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome
    • DOI 10.1016/j.gcb.2007.06.001, PII S0399832008000456
    • Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008;32:147-52 (Pubitemid 351637577)
    • (2008) Gastroenterologie Clinique et Biologique , vol.32 , Issue.2 , pp. 147-152
    • Drouault-Holowacz, S.1    Bieuvelet, S.2    Burckel, A.3    Cazaubiel, M.4    Dray, X.5    Marteau, P.6
  • 120
    • 79954738618 scopus 로고    scopus 로고
    • Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-A double-blind, placebo-controlled study
    • Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life-A double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011;33:1123-32
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 1123-1132
    • Guglielmetti, S.1    Mora, D.2    Gschwender, M.3    Popp, K.4
  • 121
    • 35448956122 scopus 로고    scopus 로고
    • Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues
    • DOI 10.1159/000103893
    • Cuomo R, Savarese MF, Gargano R. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: Consensus issues. Dig Dis 2007;25:241-4 (Pubitemid 350194176)
    • (2007) Digestive Diseases , vol.25 , Issue.3 , pp. 241-244
    • Cuomo, R.1    Savarese, M.F.2    Gargano, R.3
  • 122
    • 53149099016 scopus 로고    scopus 로고
    • Prebiotics as gut microflora management tools
    • Gibson GR. Prebiotics as gut microflora management tools. J Clin Gastroenterol 2008;42:S75-9
    • (2008) J Clin Gastroenterol , vol.42
    • Gibson, G.R.1
  • 123
    • 70350662669 scopus 로고    scopus 로고
    • Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal
    • Cani PD, Lecourt E, Dewulf EM, Sohet FM, Pachikian BD, Naslain D, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 2009;90:1236-43
    • (2009) Am J Clin Nutr , vol.90 , pp. 1236-1243
    • Cani, P.D.1    Lecourt, E.2    Dewulf, E.M.3    Sohet, F.M.4    Pachikian, B.D.5    Naslain, D.6
  • 124
    • 33947136322 scopus 로고    scopus 로고
    • Prebiotics: The concept revisited
    • Roberfroid M. Prebiotics: The concept revisited. J Nutr 2007;137:830S-7S.
    • (2007) J Nutr , vol.137
    • Roberfroid, M.1
  • 126
    • 0033661618 scopus 로고    scopus 로고
    • Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome
    • Olesen M, Gudmand-Hoyer E. Efficacy, safety, and tolerability of fructooligosaccharides in the treatment of irritable bowel syndrome. Am J Clin Nutr 2000;72:1570-5
    • (2000) Am J Clin Nutr , vol.72 , pp. 1570-1575
    • Olesen, M.1    Gudmand-Hoyer, E.2
  • 127
    • 0033006874 scopus 로고    scopus 로고
    • Controlled trial of oligofructose in the management of irritable bowel syndrome
    • Hunter JO, Tuffnell Q, Lee AJ. Controlled trial of oligofructose in the management of irritable bowel syndrome. J Nutr 1999;129:1451S-3S. (Pubitemid 29302778)
    • (1999) Journal of Nutrition , vol.129 , Issue.7 SUPPL.
    • Hunter, J.O.1    Tuffnell, Q.2    Lee, A.J.3
  • 128
    • 59149093199 scopus 로고    scopus 로고
    • Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome
    • Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009;29:508-18
    • (2009) Aliment Pharmacol Ther , vol.29 , pp. 508-518
    • Silk, D.B.1    Davis, A.2    Vulevic, J.3    Tzortzis, G.4    Gibson, G.R.5
  • 129
    • 58149137305 scopus 로고    scopus 로고
    • Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: A multicenter, randomized study
    • Andriulli A, Neri M, Loguercio C, Terreni N, Merla A, Cardarella MP, et al. Clinical trial on the efficacy of a new symbiotic formulation, Flortec, in patients with irritable bowel syndrome: A multicenter, randomized study. J Clin Gastroenterol 2008;42:S218-23
    • (2008) J Clin Gastroenterol , vol.42
    • Andriulli, A.1    Neri, M.2    Loguercio, C.3    Terreni, N.4    Merla, A.5    Cardarella, M.P.6
  • 130
    • 0030724859 scopus 로고    scopus 로고
    • Metronidazole relieves symptoms in irritable bowel syndrome: The confusion with so-called 'chronic amebiasis'
    • Nayak AK, Karnad DR, Abraham P, Mistry FP. Metronidazole relieves symptoms in irritable bowel syndrome: The confusion with so-called 'chronic amebiasis'. Indian J Gastroenterol 1997;16:137-9 (Pubitemid 27467189)
    • (1997) Indian Journal of Gastroenterology , vol.16 , Issue.4 , pp. 137-139
    • Nayak, A.K.1    Karnad, D.R.2    Abraham, P.3    Mistry, F.P.4
  • 131
    • 33644912601 scopus 로고    scopus 로고
    • A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
    • DOI 10.1111/j.1572-0241.2006.00458.x
    • Sharara AI, Aoun E, Abdul-Baki H, Mounzer R, Sidani S, Elhajj I. A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence. Am J Gastroenterol 2006;101:326-33 (Pubitemid 43381675)
    • (2006) American Journal of Gastroenterology , vol.101 , Issue.2 , pp. 326-333
    • Sharara, A.I.1    Aoun, E.2    Abdul-Baki, H.3    Mounzer, R.4    Sidani, S.5    Elhajj, I.6
  • 132
    • 0037280318 scopus 로고    scopus 로고
    • Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: A double-blind, randomized, placebo-controlled study
    • DOI 10.1016/S0002-9270(02)05902-6
    • Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol 2003;98: 412-19 (Pubitemid 36232393)
    • (2003) American Journal of Gastroenterology , vol.98 , Issue.2 , pp. 412-419
    • Pimentel, M.1    Chow, E.J.2    Lin, H.C.3
  • 133
    • 33750721328 scopus 로고    scopus 로고
    • The effect of a nonabsorbed oral antibiotic (Rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial
    • Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: A randomized trial. Ann Intern Med 2006;145:557-63 (Pubitemid 46780934)
    • (2006) Annals of Internal Medicine , vol.145 , Issue.8 , pp. 557-563
    • Pimentel, M.1    Park, S.2    Mirocha, J.3    Kane, S.V.4    Kong, Y.5
  • 134
    • 78650864077 scopus 로고    scopus 로고
    • Rifaximin therapy for patients with irritable bowel syndrome without constipation
    • Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med 2011; 364:22-32
    • (2011) N Engl J Med , vol.364 , pp. 22-32
    • Pimentel, M.1    Lembo, A.2    Chey, W.D.3    Zakko, S.4    Ringel, Y.5    Yu, J.6
  • 135
    • 0033636668 scopus 로고    scopus 로고
    • Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome
    • Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-6
    • (2000) Am J Gastroenterol , vol.95 , pp. 3503-3506
    • Pimentel, M.1    Chow, E.J.2    Lin, H.C.3
  • 136
    • 41849111638 scopus 로고    scopus 로고
    • Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls
    • DOI 10.1111/j.1572-0241.2008.01785.x
    • Bratten JR, Spanier J, Jones MP. Lactulose breath testing does not discriminate patients with irritable bowel syndrome from healthy controls. Am J Gastroenterol 2008; 103:958-63 (Pubitemid 351501116)
    • (2008) American Journal of Gastroenterology , vol.103 , Issue.4 , pp. 958-963
    • Bratten, J.R.1    Spanier, J.2    Jones, M.P.3
  • 137
    • 0142244374 scopus 로고    scopus 로고
    • Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROMEII criteria for irritable bowel syndrome
    • Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting the Rome II criteria for irritable bowel. World J Gastroenterol 2003;9:2293-9 (Pubitemid 37321463)
    • (2003) World Journal of Gastroenterology , vol.9 , Issue.10 , pp. 2293-2299
    • Portincasa, P.1    Moschetta, A.2    Baldassare, G.3    Altomare, D.F.4    Palasciano, G.5
  • 138
    • 78650874332 scopus 로고    scopus 로고
    • Antibiotic therapy for the irritable bowel syndrome
    • Tack J. Antibiotic therapy for the irritable bowel syndrome. N Engl J Med 2011;364:81-2
    • (2011) N Engl J Med , vol.364 , pp. 81-82
    • Tack, J.1
  • 139
    • 0001412472 scopus 로고
    • Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis
    • Eiseman B, Silen W, Bascom GS, Kauvar AJ. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958;44:854-9
    • (1958) Surgery , vol.44 , pp. 854-859
    • Eiseman, B.1    Silen, W.2    Bascom, G.S.3    Kauvar, A.J.4
  • 140
    • 80054736926 scopus 로고    scopus 로고
    • Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection
    • Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011;53:994-1002
    • (2011) Clin Infect Dis , vol.53 , pp. 994-1002
    • Gough, E.1    Shaikh, H.2    Manges, A.R.3
  • 141
    • 84856969539 scopus 로고    scopus 로고
    • Fecal microbiota transplantation and emerging applications
    • Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012;9:88-96
    • (2012) Nat Rev Gastroenterol Hepatol , vol.9 , pp. 88-96
    • Borody, T.J.1    Khoruts, A.2
  • 142
    • 84871638124 scopus 로고    scopus 로고
    • Fecal microbiota transplantation: Past, present and future
    • Aroniadis OC, Brandt LJ. Fecal microbiota transplantation: Past, present and future. Curr Opin Gastroenterol 2013;29: 79-84
    • (2013) Curr Opin Gastroenterol , vol.29 , pp. 79-84
    • Aroniadis, O.C.1    Brandt, L.J.2
  • 143
    • 0024970366 scopus 로고
    • Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome?
    • Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, et al. Bowel-flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989;150:604
    • (1989) Med J Aust , vol.150 , pp. 604
    • Borody, T.J.1    George, L.2    Andrews, P.3    Brandl, S.4    Noonan, S.5    Cole, P.6
  • 145
    • 0034767063 scopus 로고    scopus 로고
    • A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome
    • DOI 10.1097/00042737-200110000-00004
    • Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001;13:1143-7 (Pubitemid 33015878)
    • (2001) European Journal of Gastroenterology and Hepatology , vol.13 , Issue.10 , pp. 1143-1147
    • Niedzielin, K.1    Kordecki, H.2    Birkenfeld, B.3
  • 146
    • 0036845692 scopus 로고    scopus 로고
    • Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome
    • DOI 10.1023/A:1020597001460
    • Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002;47:2615-20 (Pubitemid 35305475)
    • (2002) Digestive Diseases and Sciences , vol.47 , Issue.11 , pp. 2615-2620
    • Sen, S.1    Mullan, M.M.2    Parker, T.J.3    Woolner, J.T.4    Tarry, S.A.5    Hunter, J.O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.